Children with prediabetes and obesity more likely to progress to diabetes Dr. Kamal Kant Kohli14 Oct 2023 10:15 AM ISTA new Journal of the Endocrine Society study highlights how to identify children at high risk of developing type 2 diabetes and strategies for...
क्या मोटापे में खर्राटे हो सकते हैं जानलेवा? Prakhar Gupta11 Oct 2023 3:22 PM ISTमोटापा, विशेष रूप से गर्दन और गले के आसपास अतिरिक्त वसा, वायुमार्ग के संकुचन का कारण बन सकता है। यह संकुचन सांस लेने के दौरान, विशेषकर नींद के दौरान...
Low muscle mass linked to two-fold risk of death from CVD in individuals with diabetes Dr. Kamal Kant Kohli10 Oct 2023 10:45 AM ISTResearchers have found in a new study that low muscle mass is associated with a two-fold risk of death from heart disease in people with diabetes....
Boehringer Ingelheim, Zealand Pharma announce initiation of 3 phase III trials investigating Survodutide for obesity Ruchika Sharma8 Oct 2023 3:30 PM ISTIngelheim: Boehringer Ingelheim and Zealand Pharma A/S have announced the initiation of three Phase III trials investigating survodutide (also known...
Biocon collaborates with Juno Pharma for commercialization of diabetes treatment Liraglutide in Canada Ruchika Sharma7 Oct 2023 11:30 AM ISTBengaluru: Biocon Limited, an innovation-led global biopharmaceutical company, has announced the signing of a partnership agreement with Juno...
Leflunomide Effective in Fighting Obesity by inducing lipophagy: Study Jacinthlyn Sylvia7 Oct 2023 11:15 AM ISTA recent study published in the FASEB Journal has uncovered a new pathway to combat obesity. Leflunomide, a medication typically used to treat...
Hybrid closed-loop technology improves blood sugar levels among pregnant women with type 1 diabetes Dr. Kamal Kant Kohli7 Oct 2023 10:30 AM ISTResearchers have found in a new study that Hybrid closed-loop technology may improve maternal glucose levels during pregnancy complicated by type 1...
Bariatric Surgery Linked to Reduced risk of Hematologic Cancer among Obese Patients Dr. Kamal Kant Kohli6 Oct 2023 11:00 AM ISTObesity has long been associated with various health risks, including an increased likelihood of developing cancer. However, a recent prospective...
Issues with Weight loss? GLP1 agonists like Semaglutide, Liraglutide may increase risk of pancreatitis, gastroparesis and bowel obstruction Dr. Kamal Kant Kohli6 Oct 2023 10:30 AM ISTUS: Researchers at University of British Columbia have found in a new study that that use of glucagon-like peptide-1 agonists for weight loss compared...
Obese women may experience worse menopause symptoms and get less relief from hormone therapy Dr. Kamal Kant Kohli3 Oct 2023 8:00 PM ISTObesity has already been associated with a number of adverse health conditions and can interfere with a person's quality of life. A new study suggests...
Novo Nordisk India head eyes 2026 weight-loss drug Wegovy launch Roshni Dhar3 Oct 2023 3:24 PM ISTDanish drugmaker Novo Nordisk aims to bring its blockbuster weight-loss drug Wegovy to India in 2026, after securing regulatory approvals and ensuring...
Novo Nordisk eyes to bring blockbuster weight-loss drug Wegovy to India in 2026 Ruchika Sharma1 Oct 2023 1:00 PM ISTNovo charges more than $1300 in the U.S. for a monthly supply and about 300 euros ($317) a month in Germany.
